scispace - formally typeset
Journal ArticleDOI

Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease

Reads0
Chats0
TLDR
In a study of adults with Crohn's disease, early azathioprine therapy was no more effective than placebo to achieve sustained corticosteroid-free remission but was more effective in preventing moderate to severe relapse in a post hoc analysis.
About
This article is published in Gastroenterology.The article was published on 2013-10-01. It has received 213 citations till now. The article focuses on the topics: Crohn's Disease Activity Index & Azathioprine.

read more

Citations
More filters
Journal ArticleDOI

Crohn's disease

TL;DR: An physician-oriented overview of Crohn's disease in adults is provided, ranging from epidemiology and cause to clinical diagnosis, natural history, patient stratification and clinical management, and ending with an overview of emerging therapies and future directions for research.
Journal ArticleDOI

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

TL;DR: These guidelines are intended to give practical (whenever possible evidence-based) answers to (pediatric) gastroenterologists who take care of children and adolescents with CD, since many different clinical scenario exist requiring treatment strategies not covered by or different from these guidelines.
Journal ArticleDOI

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

Joana Torres, +46 more
TL;DR: The present article addresses surgical management, including preoperative aspects and drug management before surgery, and provides technical advice for a variety of common clinical situations.
Journal ArticleDOI

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

TL;DR: There was no statistically significant difference in withdrawals due to adverse events or serious adverse events between antimetabolites and placebo, and azathioprine was significantly inferior to infliximab for induction of steroid-free clinical remission.
Journal ArticleDOI

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

TL;DR: An updated meta-analysis of randomized controlled trials of oral azathioprine or 6-mercaptopurine compared to placebo or active therapy involving adult patients with quiescent Crohn's disease showed that AZA was significantly superior to placebo for maintenance of remission over a 6 to 18 month period.
References
More filters
Journal ArticleDOI

Development of a Crohn's Disease Activity Index: National Cooperative Crohn's Disease Study

TL;DR: In this paper, a multiple regression computer program was utilized to derive an equation for prediction of the physician's over-all ratings from a subset of the predictor variables fulfilling a combination of constraints.
Journal ArticleDOI

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

TL;DR: Patients with moderate-to-severe Crohn's disease who were treated with infliximab plus azathioprine or inflIXimab monotherapy were more likely to have a corticosteroid-free clinical remission than those receiving azATHioprine monotherapy.
Journal ArticleDOI

National Cooperative Crohn's Disease Study: results of drug treatment.

TL;DR: Patients' drug therapy immediately before entry to the study significantly affected subsequent response, and none of the drugs was superior to placebo in prophylaxis against flare-up or recurrence.
Related Papers (5)